Net Cash Provided by (Used in) Financing Activities in USD of Sonoma Pharmaceuticals, Inc. from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from Q2 2010 to Q2 2025.
  • Sonoma Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2025 was -$58K, a 109% decline year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $3.03M, a 80.8% increase from 2023.
  • Sonoma Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.68M, a 32.7% decline from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.49M, a 66.3% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$58K -$694K -109% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q2 2024 $636K +$771K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q2 2023 -$135K +$252K +65.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q2 2022 -$387K -$178K -85.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 -$209K -$2.79M -108% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q2 2020 $2.58M +$2.72M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q2 2019 -$136K -$930K -117% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-11-17
Q2 2018 $794K +$820K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q2 2017 -$26K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q2 2014 $869K +$2.13M Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-12
Q2 2013 -$1.26M -$3.62M -153% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q2 2012 $2.37M +$1.11M +87.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q2 2011 $1.26M -$679K -35% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-31
Q2 2010 $1.94M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-09

Sonoma Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.03M +$1.35M +80.8% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-17
2023 $1.68M -$813K -32.7% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-17
2022 $2.49M -$4.91M -66.3% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-17
2021 $7.4M +$4.09M +124% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
2020 $3.31M +$2.28M +221% Apr 1, 2020 Mar 31, 2021 10-K 2022-07-13
2019 $1.03M -$4.46M -81.3% Apr 1, 2019 Mar 31, 2020 10-K 2021-07-14
2018 $5.49M Apr 1, 2018 Mar 31, 2019 10-K 2020-07-10
2012 $3.75M +$301K +8.73% Apr 1, 2012 Mar 31, 2013 10-K 2013-06-25
2011 $3.45M +$765K +28.5% Apr 1, 2011 Mar 31, 2012 10-K 2013-06-25
2010 $2.68M Apr 1, 2010 Mar 31, 2011 10-K 2012-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.